Feed RHY.AX
RH
Rhythm Biosciences Limited
RHY.AX · ASX
$0.08 -2.47% (-$0.00)
1M -4.71%
Market Cap $28.7M
P/E Ratio -
Div. Yield -
ROE 179.18%
Valuation
0 /100
Expensive P/S 8.98x
P/B 43.44x
P/E N/A
Growth
51 /100
Stable Rev. growth 9.56%
Book val. growth 55.27%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 92.95%
Net margin 119.97%
FCF margin 92.25%
Quality
14 /100
Poor ROIC 198.68%
ROE 179.18%
Asset turnover 1.13x
Debt
20 /100
High Debt/Equity 1.68x
Current ratio 0.84x
Int. coverage -55.90x
Stability
40 /100
Moderate Beta 0.43x
Rev. volatility 67.23%
Profitable years 0
Întreabă StockBot despre RHY.AX
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
David Atkins
Employees
23
Headquarters
Parkville
Evenimente viitoare
27 AUG.
Earnings
Upcoming earnings report